Key Points

• Significant improvement in laboratory participation in the LaboVIH survey (81% in 2022 vs. 69% in 2021)

• Improved completeness of the data (72% in 2022 vs. 65% in 2021)

• Increase in the HIV testing rate, exceeding the level observed in 2019 before the COVID-19 crisis

• Significant testing in the region via the VIHTest program, with over 100,000 people receiving tests without a prescription between January 2022 and June 2023

• Increase in HIV serology tests performed in laboratories without an increase in the proportion of positive results

• Number of new HIV-positive diagnoses remained stable between 2020 and 2022 (47 per million inhabitants)

• New HIV diagnoses primarily affect men aged 25–49 who have sex with men. The number of diagnoses among men who have sex with men born in France is decreasing, while it is increasing among those born abroad.

• The Nouvelle-Aquitaine region has a high proportion of HIV infections diagnosed at an early stage (34%) and a lower proportion of diagnoses at a late stage (39%) compared to other metropolitan regions.

• Increase in the initiation of pre-exposure prophylaxis (PrEP)